Log in or Sign up for Free to view tailored content for your specialty!
Bone/Mineral Metabolism News
Glucosamine supplementation may hinder type 2 diabetes development

Adults who take glucosamine supplements may be less likely to develop type 2 diabetes compared with those who do not take extra glucosamine, especially if they also have elevated levels of C-reactive protein, according to findings published in Diabetes Care.
Bone turnover markers decreased in children with type 1 diabetes

A cohort of children and adolescents with type 1 diabetes had markers of bone formation and bone resorption that were significantly decreased compared with children without diabetes, independent of diabetes duration and Tanner stages, according to findings published in Pediatric Diabetes.
Log in or Sign up for Free to view tailored content for your specialty!
Zoledronate infusion preserves BMD gains after denosumab discontinuation for women with osteoporosis

Postmenopausal women with osteoporosis who received a single infusion of zoledronate after 2 to 5 years of denosumab therapy retained more than half of bone mineral density gained before stopping treatment with no increase in vertebral fractures, according to findings published in the Journal of Bone and Mineral Research.
Smoking during pregnancy tied to increased infant fracture risk

Children born to mothers who smoked in early pregnancy were more likely to experience a fracture before age 1 year than those born to mothers who did not smoke, according to findings from a national register study published in BMJ.
Mixed-meal test reveals postprandial bone turnover suppression in abdominal obesity

Adults with abdominal obesity who participated in a mixed-meal tolerance test exhibited an acute postprandial suppression of bone turnover markers compared with the response after an oral glucose tolerance test, according to findings published in Bone.
Pheochromocytoma, paraganglioma underrecognized cause of secondary osteoporosis

Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral fracture, a hallmark of osteoporosis, when compared with adults with nonfunctional adrenal tumors, according to findings published in Bone.
Recent fracture ‘addressable risk factor’ for new fracture

Women who experience a first fragility fracture are at significant risk for experiencing subsequent fractures, particularly in the 2 years after the fracture, according to findings published in the Journal of Bone and Mineral Research.
Polygenic disease may explain increased bone fragility among children without osteogenesis imperfecta

A cohort of children presenting with increased bone fragility and no extraskeletal signs of osteogenesis imperfecta tended to have a collection of common gene variants that predispose to osteoporotic fracture rather than a monogenic etiology of their condition, according to findings published in the Journal of Bone and Mineral Research.
Delays between denosumab injections may worsen BMD response

A longer interval between denosumab injections is associated with suboptimal bone mineral density response at the spine and total hip, and strategies to improve the timely administration of denosumab in real-world settings are needed, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Air pollution contributes to low bone mineral content, BMD

Adults from India who live in areas with more air pollution have lower bone mineral content and bone mineral density compared with those living in areas with less fine particulate matter and black carbon in the air, according to findings published in JAMA Network Open.
-
Headline News
Senate committee advances NIH, FDA leaders' nominations
March 13, 20252 min read -
Headline News
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
March 14, 20255 min read -
Headline News
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
March 14, 20253 min read
-
Headline News
Senate committee advances NIH, FDA leaders' nominations
March 13, 20252 min read -
Headline News
‘We are going to have difficulty’: Untangling causes of fatigue, long COVID remains elusive
March 14, 20255 min read -
Headline News
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
March 14, 20253 min read